Evidence map›Paper›PMID 21738525›Full record

ArticleFrontiers in microbiology2011

Ribosomal protein s3: a multifunctional target of attaching/effacing bacterial pathogens.

Xiaofei Gao, Philip R Hardwidge

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Alfalfa transcriptomic responses to the field pathobiome.Plant biology (Stuttgart, Germany) · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Hedgehog pathway in sarcoma: from preclinical mechanism to clinical application.Journal of cancer research and clinical oncology · 2023
    Review
  12. Article
  13. Review
  14. Frontiers in immunology · 2023
    Article
  15. First insights into theFrontiers in microbiology · 2023
    Article
  16. Article
  17. Rat and fish peripheral blood leukocytes respond distinctively toFrontiers in cellular and infection microbiology · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Xiaofei GaoDepartment of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center Kansas City, KS, USA.
Philip R Hardwidge
University of Kansas · USUniversity of Kansas Medical Center · US

Funding

XRAY CRYSTALLOGRAPHY CORE (JANUARY 1 - JUNE 30, 2005)P20RR016443 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI VINES, CHARLOTTE M · 2001 to 2010
$21.3M
Disruption of NF-kB signaling by diarrheagenic Escherichia coliR56AI087686 · NIAID · UNIVERSITY OF KANSAS MEDICAL CENTER · PI HARDWIDGE, PHILIP ROSS · 2010 to 2010
$370k
Host subversion by E. coli O157:H7 effector proteinsR03AI076227 · NIAID · UNIVERSITY OF KANSAS MEDICAL CENTER · PI HARDWIDGE, PHILIP ROSS · 2009 to 2010
$149k
NCRR NIH HHS P20 RR016443NIAID NIH HHS R03 AI076227NIAID NIH HHS R56 AI087686
6 · The paper itself

Abstract

The extraribosomal functions of ribosomal proteins have drawn significant recent attention. Ribosomal protein S3 (RPS3), a component of the eukaryotic 40S ribosomal subunit, is a multifunctional protein that regulates DNA repair, apoptosis, and the innate immune response to bacterial infection. Here we the review the latest findings about RPS3 extraribosomal functions, with special emphasis on their relation to microbial pathogenesis and enteropathogenic Escherichia coli.

Indexed as

apoptosisDNA repairEPECextraribosomal functionNF-κBNleH1ribosomal protein S3

Identifiers

PMID21738525
PMCPMC3125523
OpenAlexW2121910747

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.